Updates are available Correction dated 2023-03-20
Click to view Correction: https://doi.org/10.1007/s10072-023-06746-4
-
Authors
Maggi, Gianpaolo
D’Iorio, Alfonsina
Aiello, Edoardo Nicolò
Poletti, Barbara
Ticozzi, Nicola
Silani, Vincenzo
Amboni, Marianna
Vitale, Carmine
Santangelo, Gabriella http://orcid.org/0000-0002-7728-852X
-
Funding
Funding for this research was provided by:
Università degli Studi della Campania Luigi Vanvitelli
- License Information
-
More Information
Article History
Received: 3 August 2022
Accepted: 9 January 2023
First Online: 18 January 2023
Change Date: 20 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10072-023-06746-4
Declarations
:
: V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology and Exploration of Neuroprotective Therapy. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l B.P is Associate Editor for Frontiers in Neuroscience. N. T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience. Remaining Authors have nothing to declare.
: Participants provided informed consent. This study was approved by the Local Ethics Committees.
